Investigators in the Division of Pulmonary, Allergy and Critical Care Medicine have made a monumental discovery regarding idiopathic pulmonary Thannickalfibrosis, an often fatal lung disease with no cure and no effective treatments. In findings published March 1, 2013, in the Journal of Clinical Investigation, the research team has discovered a new pathway that contributes to fibrosis, or scarring in the lungs. More importantly, they may have also found a potential treatment to block that pathway.

To read more, go to: http://www.uab.edu/news/latest/item/3282-uab-researchers-discover-possible-treatment-for-incurable-lung-disease

 

Good News Update
Week of February 1, 2016
State of the Department 2015
Our Shared Successes as Told by 27 Faculty and Trainees
Curtis and Geisler Honored for Contributions to Clinical Research
Both to be formally inducted into the American Society for Clinical Investigation on April 15, 2016
The Translational Story of MMP-9 and CF Lung Disease
Amit Gaggar, MD, PhD, Associate Professor of Pulmonary, Allergy, and Critical Care Medicine
Department Chair Seth Landefeld, MD, Appointed to U.S. Preventive Services Task Force

Medical Grand Rounds Calendar

RSCH Scarabelli
EOM winston
GIV Sickle